PDL BioPharma, Inc. (PDLI)

like the div. low p/e. i don't believe Obama/care will bother this one, whichever way it goes.

Yes!

PDLI's 12% current dividend is just too good to pass up. Also, there's the promise of a hefty special dividend coming up within the next couple months. That should provide some insurance against major declines that might arise from the next down-leg of our bear market or from nationalization of all health-care-related companies by the current socialist government. If the socialists lose in the 2010 mid-term elections, PDLI could do even better over a longer term. Even if the socialists win, it still took Canada more than 2 years to drop the "public-option" charade and switch to full socialist medical mode, so you should be able to escape this and all other health-related equities right around this time next year if it looks like the socialists will retain their national majority.

Looks to be on upswing, with room to grow. with a good PE for a long term investment

Very cheap stock on a PEG basis. I also like the huge dividend yield. The stock recently was upgraded by Lazard Capital.

The drugs that they license are excellent performers and they are one of the few stocks in the biopharma sector that pays a good dividend.

I wanted a biopharmaceutical company. Here is one that has begun to make some money and continues to improve steadily. P/E of only 6-point-some and a *small* market cap of 1Billion. Certainly there is room for growth in a growing industry.

dividend

Fat dividend from royalties with potential to get acquired at a premium.

PDL BioPharmaceutical focus is on development treatments for some of the worst critical life-ending diseases of mankind. While the company may or may not be successful in developing cures or palative treatments the market for any products it successfully develops could be Huge. The company has a very modest valuation given the company's future potential.

While the shares are high risk, the high risks are balanced by substantial potential rewards for investors. The Intrinsic Value of PDLI is way way more than a potential four-bagger over the next three to five years.

Kahuna, CFA

Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing 7/27 picks (late getting them in this week).

Klarman pick.

low pe high dividend

low peg ratio

Some serious insider buying going on...things that make you go 'hmmmm'

Drug company, which I usually don't like, and it makes me sick to consider investing in a company with a negative equity. However, they are making a ton of cash right now and investing champ Seth Klarman can't seem to get enough. We'll see...

building a portfolio of stocks with insider cluster buys

holding for dividend yield until 2013-4

Great Growth to P/E. Vestorvest rates it very high on long-term growth.